Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
LEVOTHYROXINE SODIUM
B & S Healthcare
H03AA01
LEVOTHYROXINE SODIUM
100 Microgram
Tablets
Product subject to prescription which may be renewed (B)
Thyroid hormones
Authorised
2012-02-10
PACKAGE LEAFLET: INFORMATION FOR THE USER ELTROXIN ® 100 MICROGRAM TABLETS (levothyroxine sodium ) Please read this leaflet carefully before you start to take your medicine. This leaflet does not contain all the information about your medicine. If you have any questions or you are not sure about anything ask your doctor or pharmacist. The name of your medicine is Eltroxin 100 microgram Tablets but will be referred to as Eltroxin Tablets. THE ACTIVE INGREDIENT IS: Each tablet contains 100 micrograms levothyroxine sodium. Eltroxin tablets are white, round, scored on one side and engraved on the other with FW31. They are packed in a blister pack of 28 tablets. The active medicine is Levothyroxine Sodium. This is the new name for Thyroxine Sodium. The ingredient itself has not changed. WHAT ELSE IS IN YOUR MEDICINE: The tablets also contain sodium citrate, lactose, maize starch, acacia powder, and magnesium stearate. MANUFACTURED BY: Custom Pharmaceuticals Ltd., Tecore House, Conway Street, Hove, East Sussex, BN3 3LW, UK PROCURED FROM WITHIN THE EU AND REPACKAGED BY THE PPA HOLDER: B&S Healthcare, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK. ELTROXIN 100MICROGRAMS TABLETS PPA NUMBER: 1328/162/001 WHAT IS YOUR MEDICINE USED FOR? Eltroxin Tablets are given to you by your doctor because you have low levels of thyroid hormone hypothyroidism) and your metabolism is lower than normal. Thyroid hormone is vital for normal growth and development. Eltroxin Tablets make up for this lack of naturally occurring thyroid hormone. These tablets can be used for long term treatment. BEFORE YOU TAKE YOUR MEDICINE: If the answer is yes to any of the following question Belgenin tamamını okuyun
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Eltroxin 100 microgram Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 100 micrograms anhydrous levothyroxine sodium. Excipients: also contains lactose monohydrate For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet _Product imported from the UK:_ A white, round tablet, scored on one side and engraved on the other with FW31 The scoreline is to allow for breaking for ease of swallowing and not to divide into equal doses 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Recommended clinical indications: Control of hypothyroidism, congenital hypothyroidism and juvenile myxoedema. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults: Initially 50 to 100 micrograms daily, preferably taken before breakfast. Adjust at three to four week intervals by 50 micrograms until normal metabolism is steadily maintained: this may require doses of 100 to 200 micrograms daily. For patients over 50 years, it is not advisable to exceed 50 micrograms daily initially and where there is cardiac disease, 25 micrograms daily or 50 micrograms on alternate days is more suitable initially. In this condition the daily dose may be increased by 25 micrograms at intervals of perhaps 4 weeks. For patients younger than 50 years, and in the absence of heart disease, a serum thyroxine (T4) level of 70 to 160 nanomols per litre, or a serum thyrotrophin level of less than 5 milli-units per litre should be targeted. For patients aged over 50 years, with or without cardiac disease, clinical response is probably a more acceptable criterion of dosage rather than serum levels. A pre-therapy ECG is valuable because ECG changes due to hypothyroidism may be confused with ECG evidence of cardiac ischaem Belgenin tamamını okuyun